MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL)

CUSIP: 558868105

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock
Shares outstanding
22,766,960
Total 13F shares
10,962,747
Share change
-252,180
Total reported value
$874,847,601
Put/Call ratio
65%
Price per share
$79.79
Number of holders
126
Value change
-$34,316,604
Number of buys
52
Number of sells
64

Quarterly Holders Quick Answers

What is CUSIP 558868105?
CUSIP 558868105 identifies MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BAKER BROS. ADVISORS LP
13F
Company
6.6%
1,499,213
$146,038,000 30 Jun 2021
13F
Avoro Capital Advisors LLC
13F
Company
6.3%
1,425,000
$138,809,000 30 Jun 2021
13F
VANGUARD GROUP INC
13F
Company
4.6%
1,049,310
$102,213,000 30 Jun 2021
13F
BlackRock Finance, Inc.
13F
Company
4%
909,817
$88,627,000 30 Jun 2021
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
3.8%
867,766
$84,529,000 30 Jun 2021
13F
STATE STREET CORP
13F
Company
2.7%
622,462
$60,634,000 30 Jun 2021
13F
ARMISTICE CAPITAL, LLC
13F
Company
2.6%
592,000
$57,667,000 30 Jun 2021
13F
Capital Research Global Investors
13F
Company
2%
466,422
$45,434,000 30 Jun 2021
13F
Rock Springs Capital Management LP
13F
Company
1.2%
262,500
$25,570,000 30 Jun 2021
13F
Artisan Partners Limited Partnership
13F
Company
0.97%
220,687
$21,497,000 30 Jun 2021
13F
CITIGROUP INC
13F
Company
0.87%
198,601
$19,346,000 30 Jun 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.87%
198,104
$19,297,000 30 Jun 2021
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.74%
169,172
$16,479,000 30 Jun 2021
13F
FMR LLC
13F
Company
0.73%
166,540
$16,223,000 30 Jun 2021
13F
L1 Capital Pty Ltd
13F
Company
0.72%
164,860
$16,059,000 30 Jun 2021
13F
CITADEL ADVISORS LLC
13F
Company
0.71%
160,995
$15,682,000 30 Jun 2021
13F
NORTHERN TRUST CORP
13F
Company
0.5%
114,862
$11,188,000 30 Jun 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.48%
109,287
$10,646,000 30 Jun 2021
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.44%
100,000
$9,741,000 30 Jun 2021
13F
MARSHALL WACE, LLP
13F
Company
0.43%
98,180
$9,563,000 30 Jun 2021
13F
Marshall Wace North America L.P.
13F
Company
0.42%
95,380
$9,290,000 30 Jun 2021
13F
MORGAN STANLEY
13F
Company
0.41%
93,672
$9,126,000 30 Jun 2021
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.37%
84,940
$8,274,000 30 Jun 2021
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.33%
76,255
$7,428,000 30 Jun 2021
13F
NORGES BANK
13F
Company
0.32%
73,659
$7,175,000 30 Jun 2021
13F
Hennion & Walsh Asset Management, Inc.
13F
Company
0.32%
73,564
$7,166,000 30 Jun 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.32%
72,282
$7,041,000 30 Jun 2021
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.3%
68,235
$6,647,000 30 Jun 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.26%
60,268
$5,871,000 30 Jun 2021
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.23%
52,982
$5,161,000 30 Jun 2021
13F
Tao Capital Management LP
13F
Company
0.23%
51,396
$5,007,000 30 Jun 2021
13F
Maven Securities LTD
13F
Company
0.22%
50,000
$4,911,000 30 Jun 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.2%
45,883
$4,469,000 30 Jun 2021
13F
Bank of New York Mellon Corp
13F
Company
0.17%
39,810
$3,878,000 30 Jun 2021
13F
Parkman Healthcare Partners LLC
13F
Company
0.16%
36,393
$3,545,000 30 Jun 2021
13F
Squarepoint Ops LLC
13F
Company
0.14%
32,587
$3,174,000 30 Jun 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.14%
30,970
$3,017,000 30 Jun 2021
13F
MACQUARIE GROUP LTD
13F
Company
0.13%
28,751
$2,800,000 30 Jun 2021
13F
Polar Asset Management Partners Inc.
13F
Company
0.12%
28,100
$2,737,000 30 Jun 2021
13F
Cubist Systematic Strategies, LLC
13F
Company
0.12%
27,664
$2,695,000 30 Jun 2021
13F
Deutsche Girozentrale DekaBank
13F
Individual
0.11%
25,750
$2,489,000 30 Jun 2021
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.11%
24,770
$2,413,000 30 Jun 2021
13F
SG Americas Securities, LLC
13F
Company
0.11%
24,591
$2,395,000 30 Jun 2021
13F
Rafferty Asset Management, LLC
13F
Company
0.11%
24,165
$2,354,000 30 Jun 2021
13F
Ikarian Capital, LLC
13F
Company
0.1%
23,654
$2,303,000 30 Jun 2021
13F
ALPS ADVISORS INC
13F
Company
0.1%
21,744
$2,118,000 30 Jun 2021
13F
D. E. Shaw & Co., Inc.
13F
Company
0.09%
21,412
$2,086,000 30 Jun 2021
13F
Swiss National Bank
13F
Company
0.09%
21,200
$2,065,000 30 Jun 2021
13F
DEUTSCHE BANK AG\
13F
Company
0.09%
20,127
$1,961,000 30 Jun 2021
13F
Man Group plc
13F
Company
0.08%
18,700
$1,822,000 30 Jun 2021
13F

Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q3 2021

As of 30 Sep 2021, MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) was held by 126 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,962,747 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., STATE STREET CORP, Rock Springs Capital Management LP, Artisan Partners Limited Partnership, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 126 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
147
Q3 2021 holders
126
Holder diff
-21
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 Value $ Q3 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.